Figure 5C, D shows the adjusted AD risk prediction with CIs for each lipid group over a range of ages for patients with no APOE-ε4 alleles, APOE-ε4 heterozygotes, and APOE-ε4 homozygotes. This evidence concerns the gene APOE and Alzheimer disease.